Activation of blood T lymphocytes down‐regulates CXCR4 expression and interferes with propagation of X4 HIV strains
暂无分享,去创建一个
M. Baggiolini | P. Loetscher | E. Oberlin | F. Arenzana‐Seisdedos | J. Martin-Serrano | J. Alcamí | A. Serrano | B. Santiago | A. Caruz | M. Bermejo | M. Pedraza | Antonio Serrano
[1] S. O’Brien,et al. Exclusive and Persistent Use of the Entry Coreceptor CXCR4 by Human Immunodeficiency Virus Type 1 from a Subject Homozygous for CCR5 Δ32 , 1998, Journal of Virology.
[2] G. Suzuki,et al. Disturbed CD4+ T Cell Homeostasis and In Vitro HIV-1 Susceptibility in Transgenic Mice Expressing T Cell Line–tropic HIV-1 Receptors , 1998, The Journal of experimental medicine.
[3] J. Moore,et al. Expression patterns of the HIV type 1 coreceptors CCR5 and CXCR4 on CD4+ T cells and monocytes from cord and adult blood. , 1998, AIDS research and human retroviruses.
[4] T. Proft,et al. Superantigens: Just Like Peptides Only Different , 1998, The Journal of experimental medicine.
[5] T. Springer,et al. B Lymphocyte Chemotaxis Regulated in Association with Microanatomic Localization, Differentiation State, and B Cell Receptor Engagement , 1998, The Journal of experimental medicine.
[6] C. Mackay,et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. , 1998, The Journal of clinical investigation.
[7] E. Kremmer,et al. Intracellular and surface expression of the HIV-1 coreceptor CXCR4/fusin on various leukocyte subsets: rapid internalization and recycling upon activation. , 1998, Journal of immunology.
[8] M. Baggiolini,et al. CCR5 is characteristic of Th1 lymphocytes , 1998, Nature.
[9] E. Butcher,et al. Chemokines and the arrest of lymphocytes rolling under flow conditions. , 1998, Science.
[10] J J Goedert,et al. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC) , 1998, Science.
[11] B. Korber,et al. A new classification for HIV-1 , 1998, Nature.
[12] Luc Montagnier,et al. HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene , 1998, The Lancet.
[13] S. Mummidi,et al. The Human CC Chemokine Receptor 5 (CCR5) Gene , 1997, The Journal of Biological Chemistry.
[14] A. Blauvelt,et al. Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: Implications for HIV primary infection , 1997, Nature Medicine.
[15] T. Schall,et al. Identification and Molecular Characterization of Fractalkine Receptor CX3CR1, which Mediates Both Leukocyte Migration and Adhesion , 1997, Cell.
[16] R. Snyderman,et al. Regulation of Human Chemokine Receptors CXCR4 , 1997, The Journal of Biological Chemistry.
[17] J. Hoxie,et al. Phorbol Esters and SDF-1 Induce Rapid Endocytosis and Down Modulation of the Chemokine Receptor CXCR4 , 1997, The Journal of cell biology.
[18] E. Fenyö,et al. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression , 1997, Nature Medicine.
[19] J. Albert,et al. The influence of MT‐2 tropism on the prognostic implications of the Δ32 deletion in the CCR‐5 gene , 1997, AIDS.
[20] E. Meese,et al. TYMSTR, a putative chemokine receptor selectively expressed in activated T cells, exhibits HIV-1 coreceptor function , 1997, Current Biology.
[21] J J Goedert,et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. , 1997, Science.
[22] C. Martínez-A,et al. The amino-terminal domain of the CCR2 chemokine receptor acts as coreceptor for HIV-1 infection. , 1997, The Journal of clinical investigation.
[23] Jean Salamero,et al. HIV Coreceptor Downregulation as Antiviral Principle: SDF-1α–dependent Internalization of the Chemokine Receptor CXCR4 Contributes to Inhibition of HIV Replication , 1997, The Journal of experimental medicine.
[24] H. Nomiyama,et al. Identification of CCR6, the Specific Receptor for a Novel Lymphocyte-directed CC Chemokine LARC* , 1997, The Journal of Biological Chemistry.
[25] K. Peden,et al. STRL33, A Novel Chemokine Receptor–like Protein, Functions as a Fusion Cofactor for Both Macrophage-tropic and T Cell Line–tropic HIV-1 , 1997, The Journal of experimental medicine.
[26] J. Sodroski,et al. CCR5 Levels and Expression Pattern Correlate with Infectability by Macrophage-tropic HIV-1, In Vitro , 1997, The Journal of experimental medicine.
[27] C. Mackay,et al. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[28] J. Mascola,et al. The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression , 1997, Nature Medicine.
[29] R. Connor,et al. Change in Coreceptor Use Correlates with Disease Progression in HIV-1–Infected Individuals , 1997, The Journal of experimental medicine.
[30] William C. Olson,et al. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5 , 1996, Nature.
[31] J. Fraser,et al. Cross-linking of MHC class II molecules by staphylococcal enterotoxin A is essential for antigen-presenting cell and T cell activation. , 1996, Journal of immunology.
[32] D. Dimitrov,et al. Evidence for Cell-Surface Association Between Fusin and the CD4-gp120 Complex in Human Cell Lines , 1996, Science.
[33] S. Hammer,et al. The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team. , 1996, The New England journal of medicine.
[34] J J Goedert,et al. Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene , 1996, Science.
[35] Simon A. Jones,et al. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes , 1996, The Journal of experimental medicine.
[36] T. Springer,et al. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1) , 1996, The Journal of experimental medicine.
[37] Bernhard Moser,et al. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1 , 1996, Nature.
[38] J. Sodroski,et al. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry , 1996, Nature.
[39] M. Baggiolini,et al. Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes , 1996, The Journal of experimental medicine.
[40] Ying Sun,et al. The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates , 1996, Cell.
[41] C. Broder,et al. CC CKR5: A RANTES, MIP-1α, MIP-1ॆ Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1 , 1996, Science.
[42] Virginia Litwin,et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5 , 1996, Nature.
[43] Paul E. Kennedy,et al. HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor , 1996, Science.
[44] D. Ho,et al. Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalization and selection during sexual transmission , 1996, Journal of virology.
[45] R. Steinman,et al. Dendritic cells and the replication of HIV‐1 , 1996, Journal of leukocyte biology.
[46] A I Spira,et al. Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques , 1996, The Journal of experimental medicine.
[47] P. Gray,et al. Chemokine expression in murine experimental allergic encephalomyelitis , 1995, Journal of Neuroimmunology.
[48] R. Gaynor,et al. Absolute dependence on kappa B responsive elements for initiation and Tat‐mediated amplification of HIV transcription in blood CD4 T lymphocytes. , 1995, The EMBO journal.
[49] S. Webb,et al. T-cell activation by superantigens. , 1994, Current opinion in immunology.
[50] T. Springer. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm , 1994, Cell.
[51] T. Geiser,et al. Cloning of a human seven-transmembrane domain receptor, LESTR, that is highly expressed in leukocytes. , 1994, The Journal of biological chemistry.
[52] I. Keet,et al. Prognostic Value of HIV-1 Syncytium-Inducing Phenotype for Rate of CD4+ Cell Depletion and Progression to AIDS , 1993, Annals of Internal Medicine.
[53] H. Coste,et al. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. , 1991, The Journal of biological chemistry.
[54] R. Aebersold,et al. Chemical synthesis, purification, and characterization of two inflammatory proteins, neutrophil activating peptide 1 (interleukin-8) and neutrophil activating peptide. , 1991, Biochemistry.
[55] Jerome A. Zack,et al. HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure , 1990, Cell.
[56] C. Mackay,et al. Naive and memory T cells show distinct pathways of lymphocyte recirculation , 1990, The Journal of experimental medicine.
[57] J. Virelizier. Cellular activation and human immunodeficiency virus infection. , 1990, Current opinion in immunology.
[58] H. Gendelman,et al. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone , 1986, Journal of virology.
[59] B Dewald,et al. Human chemokines: an update. , 1997, Annual review of immunology.
[60] C. Broder,et al. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. , 1996, Science.
[61] T. Springer,et al. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. , 1995, Annual review of physiology.
[62] R. Gaynor,et al. Absolute dependence on KB responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD 4 T lymphocytes , 2022 .